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Edited by Laszlo NagyAbstract Mycobacterial lipomannan (LM) and lipoarabino-
mannan (LAM) regulate macrophage activation by interacting
with Toll-like receptors (TLRs). The intracellular signalling
pathways elicited by these complex molecules are poorly deﬁned.
We have demonstrated that LM puriﬁed from various mycobac-
terial species, but not LAM from Mycobacterium kansasii or
Mycobacterium bovis BCG, induced expression of the MAP
kinase phosphatase 1 (MKP-1) in macrophages. Anti-TLR2
antibodies, as well as speciﬁc ERK and p38 MAPK inhibitors,
decreased MKP-1 transcription in LM-stimulated cells. These
ﬁndings suggest that the binding of LM to TLR2 triggers
MAPK activation, followed by an up-regulation of MKP-1
expression, which in turn may act as a negative regulator of
MAPK activation.
 2008 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The mycobacterial cell wall contains a wide array of glyco-
lipids, including lipoarabinomannan (LAM) and its related
biosynthetic precursor lipomannan (LM), which modulate
the innate immune system [1–4]. LAM found in Mycobacte-
rium tuberculosis, Mycobacterium bovis BCG or Mycobacte-
rium kansasii, inhibits the bactericidal properties of
macrophages, thus promoting intracellular survival of the
pathogen [2,4,5]. LM puriﬁed from various strains of myco-
bacteria displays both pro-inﬂammatory through Toll-like
receptor 2 (TLR2) and anti-inﬂammatory eﬀects via TLR2-
independent pathways [6–10]. TLR2 activation by mycobacte-
ria triggers the activation of NF-jB and mitogen activatedAbbreviations: LM, lipomannan; LAM, lipoarabinomannan; MKP-1,
MAP kinase phosphatase 1; TLR, Toll-like receptor; MAPK, mitogen
activated protein kinases; DC-SIGN, dendritic cell-speciﬁc ICAM-3
grabbing non-integrin; ManLAM, mannose-capped lipoarabinomann;
PILAM, phosphoinositol-capped lipoarabinomannan
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doi:10.1016/j.febslet.2008.01.007protein kinases (MAPK) pathways, thus leading to modula-
tion of inﬂammatory genes transcription [11–14]. MAPKs
are a family of serine/threonine kinases comprising the extra-
cellular signal-regulated kinase (ERK1/2), the c-jun N-termi-
nal (JNK) and the p38 MAPK. The modulation of MAPK
signalling pathways may contribute to mycobacterial patho-
genesis. Indeed, during macrophage infection by mycobacteria,
MAPKs are involved in cytokine production, phagosome acid-
iﬁcation, apoptosis, and antigen presentation [14]. MAPKs can
be inactivated speciﬁcally by a family of phosphatases (MKP)
through dephosphorylation of their tyrosine and threonine res-
idues, thereby limiting cytokine biosynthesis in immune cells
[15,16]. Both MAPK activation and expression of MKP-1 in
macrophages are induced in response to bacterial components,
mainly lipopolysaccharide (LPS) [17–19]. LPS stimulates a
transient phosphorylation of MAPKs which stimulate MKP-
1 expression leading to down-regulation of MAPK activity
[16–19]. Thereby, the transcription and translational activation
of MKP-1 is regulated at multiple levels by complex mecha-
nisms including ERK, p38 and JNK-dependent pathway
[17–20]. This mechanism plays a crucial role in the feedback
control of macrophage activation.
Despite these recent studies that have revealed the essential
role of MAPK signalling during infection by mycobacteria,
the multiplicity of intracellular signalling cascades elicited in
macrophages by mycobacterial components are poorly under-
stood. Up to now, the possible induction of MKP-1 by LM
and/or LAM has not been examined. In this study, we have
investigated the eﬀect of LM and LAM, puriﬁed from several
mycobacterial species (including opportunistic and pathogenic
species) on the induction of MKP-1 mRNA expression from
human macrophage-like diﬀerentiated THP-1 cells. We also
investigated the possible involvement of TLR2 and MAPK
pathways in MKP-1 gene expression in response to LM stim-
ulation.2. Material and methods
2.1. Materials and reagents
Speciﬁc inhibitors of MAPK and 1,25-dihydroxy-vitamin D3 were
purchased from Calbiochem. Rabbit polyclonal antibodies (anti-phos-
pho-p38, anti-human MKP-1), mouse monoclonal anti-phospho-ERK
and anti-JNK were obtained from Santa Cruz Technology. Rabbit
polyclonal antibodies directed against phospho-JNK, b actin andblished by Elsevier B.V. All rights reserved.
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whereas polyclonal anti-ERK antibodies were from Sigma.
Neutralizing mouse anti-TLR2 monoclonal antibodies (clone TL2-1)
and a mouse isotype control antibody were provided from Biolegend
and from eBiosciences, respectively.2.2. Extraction and puriﬁcation of LM and LAM
LM and LAM from Mycobacterium chelonae (ATTC 19538), M.
kansasii (PHR1901, a clinical isolate), M. bovis BCG (Pasteur strain)
and Mycobacterium smegmatis were puriﬁed, as previously described
[21,22]. Endotoxin contamination of each preparation was determined
by the chromogenic Limulus lyzate assay (QCL1000; BioWhittaker).2.3. Cell culture
Human pro-monocytic leukaemia THP-1 cells (ECACC No.
88081201) were grown in RPMI 1640 supplemented with 10% FCS,
2 mM L-glutamine in a 5% CO2–air humidiﬁed atmosphere at 37 C.
Cells were diﬀerentiated in macrophages, by addition of 1,25-dihy-
droxy-vitamin D3 (50 nM) for 72 h.MKP-1
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3 · 106 diﬀerentiated THP-1 cells were incubated at 37 C with var-
ious lipoglycans (10 lg/ml for LM and 20 lg/ml for LAM) in RPMI/
glutamine serum-free medium. At various time points, total RNAs
were puriﬁed using the Nucleospin RNA II Kit (Macherey-Nagel, Du¨-
ren, Germany). Reverse transcription (RT) and PCR ampliﬁcation
were performed as described previously [23], by using primer pairs
(Eurogentec) designed for the speciﬁc detection of human MKP-1,
5 0-GCTGTGCAGCAAACAGTCGA-3 0 (forward primer) and 5 0-
CGATTAGTCCTCATAAGGTA-3 0 (reverse primer), at 55 C for
26 cycles. GAPDH was included as an internal control using the
following primer pair: 5 0-GGTGGACCTGACCTGCCGTCTA-30
(forward primer) and 5 0-GAGGTCCACCACCCTGTTGCTG-3 0
(reverse primer) (69 C, 18 cycles). PCR products (432 pb and 240 pb
forMKP-1 and GAPDH, respectively) were separated by electrophore-
sis on a 2% agarose gel. Gels were analyzed by computerized densito-
metric imaging with the Bio-Rad GelDoc analysis system and Quantity
One software, version 4.1.0 (Bio-Rad).
The eﬀect of MAPK inhibitors on MKP1 mRNA synthesis was
investigated as described above, except that cells were pre-incubated
for 30 min with each MAPK inhibitor (10 lM SB203580, 10 lM
U0126 and 25 lM SP600125, dissolved in DMSO) prior to the addi-
tion of each lipoglycan.
In order to investigate the participation of TLR2 in the MKP1
expression, cells were pre-treated for 30 min at 37 C with 15 lg/ml
of neutralizing anti-TLR2 antibodies, and then stimulated for 2 h with
either 10 lg/ml of LM puriﬁed from M. kansasii (called KanLM) or
20 lg/ml of phosphoinositol-capped LAM (called PILAM) found in
M. smegmatis. The corresponding isotype control was used as negative
control. Statistical signiﬁcance of diﬀerence was calculated by using the
students test. Values of P < 0.05 were considered to be signiﬁcant.KanLM (10 µg/ml)
0          30mn         1h        2h        3h          5h
KanLM (10 µg/ml)
MKP-1
β actin
Fig. 1. Time course induction of MKP-1 gene expression in diﬀeren-
tiated THP-1 cells in response to KanLM. Cells were incubated with
KanLM (10 lg/ml) for the indicated times. (A) MKP-1 and GAPDH
mRNA expression were determined by RT-PCR, as described in
Materials and methods. The ratio of the ﬂuorescence intensities of
MKP-1 and GAPDH PCR products are plotted in the bar graphs. Bar
charts are expressed as mean values ± S.E.M. Results are representa-
tive of three independent experiments. (B) MKP-1 protein induced by
KanLM was detected by Western blot analysis using speciﬁc anti-
MKP-1 antibodies. An anti-b-actin antibody was used to control the
sample loading. The ﬁgure is representative of three experiments with
similar results.2.5. Western blot analysis
After stimulation with 10 lg/ml of LM, cells were lysed for 3 h at
4 C in buﬀer (20 mM phosphate buﬀer saline pH 7.4, 200 mM NaCl,
10 mM KCl, 1 mM EDTA, 1% triton X-100, 20% glycerol, 10 mM
NaF, 1 mM Na3VO4) supplemented with protease inhibitor cocktail
(Roche) and sonicated for 5 s. After centrifugation, proteins were sep-
arated by 10% SDS–PAGE and electrotransferred onto a nitrocellu-
lose membrane. The membrane was incubated in blocking buﬀer (3%
BSA in Tris–Buﬀer Salin: 20 mM Tris/Hcl, 150 mM NaCl, 1 mM
EDTA, 0.1% Tween 20) for 2 h at room temperature and probed with
the speciﬁc anti-phosphoMAPK antibodies, overnight at 4 C. After
washings, blots were incubated with horseradish peroxidase-conju-
gated secondary antibodies for 1 h 30 min at room temperature and re-
vealed using the Chemiluminescence Detection Kit ECL (Amersham).
Anti-total MAPK protein antibodies were included as a control of
sample loading. Both phospho-ERK1 (44 kDa) and phospho-ERK2
(42 kDa) were detected by anti-phospho-ERK antibodies whereas
anti-phospho JNK detected two JNK isoforms of 55 and 46 kDa.
MKP-1 protein was detected using rabbit polyclonal anti human
MKP-1 antibodies and blots were reprobed with anti b-actin antibody
in order to conﬁrm equal loading in each lane.3. Results
3.1. Induction of MKP-1 expression from diﬀerentiated THP-1
cells in response to mycobacterial LM and LAM
stimulation
Previous studies have reported that LM modulates the mac-
rophage cell activation [2,6,7]. Given the importance of MKP-
1 in the regulation of intracellular signalling pathways during
microbial infection [16,17], we investigated the capacity of
LM isolated from diﬀerent mycobacterial species to trigger
the expression of human MKP-1 on human macrophage-like
diﬀerentiated THP-1 cells.
We analyzed the kinetic of MKP-1 gene expression in the
presence of LM puriﬁed from M. kansasii (KanLM) by RT-
PCR. As shown in Fig. 1A, MKP-1 mRNA synthesis was
strongly up-regulated after 30 min in response to KanLM
stimulation, reaching the maximal level after 1 h, before
decreasing after 3 h or 5 h of stimulation. Expression levels
of GAPDH mRNA, a housekeeping gene product included
as an internal control, remained unchanged.
To investigate KanLM-dependent MKP-1 expression at a
translational level, the MKP-1 protein, which is expressed as
a 39 kDa protein, was detected by Western blotting using spe-
ciﬁc anti-MKP-1 antibodies. As illustrated in Fig. 1B, the
MKP-1 protein was transiently induced by KanLM in cells
after 1 h of exposure with KanLM. The expression level of
the b-actin control was unchanged, indicating that equal
amounts of proteins were loaded in each lane. These results
are in agreement with the RT-PCR analysis and suggest that
LMs are potent MKP-1-inducing factors.
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mycobacterial species including M. chelonae (CheLM),
M. smegmatis (SmegLM), M. bovis BCG (BCGLM) as well
as their corresponding arabinosylated counterparts (LAM),
display a similar stimulating MKP-1 gene expression capacity.
LAMs are classiﬁed into three structural families according to
the structure of capping motif [1,2]: mannose-capped lipoarabi-
nomann (ManLAM) when capped with oligomannosides pres-
ent in M. tuberculosis, Mycobacterium leprae, Mycobacterium
avium and M. kansasii [1,22,24], the phosphoinositol-capped
LAM (PILAM) found in M. smegmatis, [25] and AraLAM
when uncapped inM. chelonae [21]. Herein, we have compared
the MKP-1-inducing capacities of the three families of LAM.
As shown in Fig. 2A, all LM subtypes and PILAM from
M. smegmatis were potent MKP-1-inducing factors in diﬀeren-
tiated THP-1 cells. In contrast, ManLAM from M. bovis BCG
(BCGLAM) and M. kansasii (KanLAM) and AraLAM from
M. chelonae (CheLAM) stimulated weaklyMKP-1 gene expres-
sion (P < 0.05 compared to unstimulated cells).
Altogether, these results establish that only LM and PILAM
induce MKP-1 gene expression in human macrophages.
3.2. Up-regulation of MKP-1 expression by KanLM and
PILAM is mediated through a TLR2-dependent pathway
Several studies have reported that the activation of diﬀeren-
tiated THP-1 cells or primary murine macrophages by LM isMKP-1
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Fig. 2. MKP-1 gene expression in response to diﬀerent LM or LAM, puriﬁed
antibodies. (A) Cells were stimulated for 2 h with various LM (10 lg/ml) or L
determined by RT-PCR. Results are representative of three independent
antibodies. Cells were pre-treated with 15 lg/ml of anti-TLR2, or control iso
(10 lg/ml) or PILAM (20 lg/ml).mediated by TLR2 which modulates the innate immune system
by triggering the secretion of pro-inﬂammatory cytokines [6,8].
Moreover, MKP-1 biosynthesis is dependent on engagement
on TLR [15]. To address whether ligation to TLR2 aﬀects
the MKP-1-inducing activity of KanLM or PILAM, cells were
pre-treated with neutralizing anti-TLR2 and then stimulated
with each lipoglycan to allow MKP-1 expression. MKP-1 gene
expression was analyzed by RT-PCR (Fig. 2B). Neutralizing
anti-TLR2 antibodies, but not the control isotype antibody,
strongly prevented expression of MKP-1 by KanLM or PI-
LAM. Altogether, these data suggest that ligation to TLR-2
plays a crucial role in the MKP-1 expression by LM or PI-
LAM.
3.3. Stimulation of diﬀerentiated THP-1 cells with KanLM
causes an activation of MAPK
Considering that the expression of MKP-1 can be induced
and regulated by MAPKs [17] and that no information is cur-
rently available regarding to MAPK stimulation by LM, we
have investigated whether MAPK could be activated by Kan-
LM in cells. The kinetic parameters of phosphorylation of
ERK, JNK and p38 MAPK were examined by Western blot-
ting using anti-phospho MAPK antibodies. As shown in
Fig. 3, ERK, JNK and p38 MAPK were activated in a time-
dependent manner following stimulation with KanLM. Phos-
phorylation of ERK and p38 MAPK reached maximal levels2
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from various mycobacterial species and inhibitory eﬀect of anti-TLR2
AM (20 lg/ml). Levels ofMKP-1 and GAPDH mRNA expression were
experiments. (B) Inhibition of the MKP-1 expression by anti-TLR2
type antibodies for 30 min at 37 C, prior to the addition of KanLM
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Fig. 3. MAPKinase activation by KanLM in diﬀerentiated THP-1
cells. Cells were stimulated with 10 lg/ml of KanLM for various
periods times. Lysates were analyzed by Western blotting using speciﬁc
anti-phospho MAPK antibodies recognizing phosphorylated forms of
ERK, JNK and p38 MAPK (P-ERK, P-JNK, P-p 38). Equal loading
of samples was also demonstrated by using anti-ERK, anti-p38 and
anti-JNK antibodies. Results are representative of three independent
experiments.
448 E. Elass et al. / FEBS Letters 582 (2008) 445–450between 20 and 40 min and then returned to basal levels at
90 min. In contrast to ERK and p38 MAPK, JNK was not
inactivated even after 90 min.
3.4. Transcriptional induction of MKP-1 by KanLM is mediated
primarily by ERK and p38
To further examine the respective roles of MAPKs in induc-
tion of MKP-1 by KanLM, we have tested whether speciﬁc
inhibitors of these pathways could alter MKP-1 expression in
KanLM-stimulated THP-1 cells. Pre-treatment of cells with
either U0126, an inhibitor of the MEK/ERK-1/2 cascade, or
SB203580, an inhibitor of the p38 MAPK pathway, resulted
in inhibitions of MKP-1 mRNA expression by about 62%
and 38%, respectively (Fig. 4A and B). Pre-treatment with
SP600125, an inhibitor of JNK isoforms, had only a modest- + - +
- - + +
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Fig. 4. Role of MAPK activity on KanLM mediated MKP-1 induction. Cell
(U0126, SB203580 and SP600125) and then stimulated with KanLM (10 lg/
determined by RT-PCR. (B) Results are expressed as percentages of the MK
the absence of inhibitors were arbitrarily placed at 100%. Data represent thinhibitory eﬀect (12% inhibition). As shown in control experi-
ments without LM, these inhibitors did not modify the GAP-
DHmRNA levels. Together, these results indicate that
induction of MKP-1 expression by LM is strongly dependent
on regulation by ERK and p38 MAPK.4. Discussion
Recent studies have revealed the complexity of TLR-medi-
ated intracellular signalling pathways upon mycobacterial
infection [14]. Interaction of pathogens with TLR triggers both
NF-jB-dependent and MAPK pathways. MAPK induce
TNF-a and IL-12 production by enhancing both gene tran-
scription via AP-1 and, the translation and stability of cyto-
kine mRNAs. Modulation of MAPK activity in macrophage
plays a crucial role in governing antibacterial defence mecha-
nisms [16,17]. The success of pathogenic mycobacteria depends
on its ability to tolerate and manipulate host defense mecha-
nisms. Thus, the intracellular growth control of M. avium
was dependent on the extent of MAPK phosphorylation in
macrophages [11,26]. Speciﬁc phosphatases like MKP-1, mod-
ulate the strength and duration of the MAPK transduced
signals thereby preventing an excessive production of pro-
inﬂammatory cytokines in innate immune cells exposed to
microbial components [18,19]. MKP-1 may negatively regulate
innate immune functions as suggested by overexpression of
MKP-1 in immortalized macrophages [27]. MKP-1 synthesis
is transiently induced in macrophages by LPS or peptidoglycan
through a TLR4 or a TLR2-dependent mechanism, respec-
tively [15–17]. Indeed, the NF-jB and MAPK pathways elic-
ited by LPS, leading to a rapid secretion of TNF-a, are
followed by the induction of MKP-1, which in turn acts as a
negative feedback control to inactivate ERK, p38 and JNK.
This mechanism down-regulates the production of cytokines
[15]. In this context, we have investigated whether LM, known- + - +
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tion in macrophage, might also be a potent MKP-1 inducing
factor. Herein, we have shown that MKP1 mRNA was tran-
siently induced in macrophagic THP-1 cells by LM puriﬁed
from diﬀerent mycobacterial species. Inhibition studies using
anti-TLR2 antibodies clearly indicate that this eﬀect was med-
iated by TLR2. To elucidate the role of MAPK in the LM re-
sponse for MKP-1 expression, activation of MAPK by LM
was investigated. KanLM elicited phosphorylation of three
MAPKs, ERK, JNK and p38, in diﬀerentiated THP-1 cells.
Both ERK and p38 were inactivated after 60 min of stimula-
tion with KanLM. This down-regulation of p38 and ERK
may be correlated to the induction of MKP-1. In addition,
we provide evidence that U0126, SB203580 and to a lesser ex-
tent SP10065, described as MEK/2, p38 and JNK inhibitors,
respectively, partially blocked induction of MKP-1 gene
expression by KanLM. These results emphasize the impor-
tance of ERK and p38 pathways in up-regulation of MKP-1
by mycobacterial LM. Gene induction of MKP-1 by LPS in
macrophagic cells was also described as ERK-dependent [18].
Our results demonstrate that PILAM from M. smegmatis also
induced MKP-1 gene expression. This result is consistent with
previous studies reporting that LM and PILAM exhibit similar
biological activities, dependent on TLR2 activation [3,6,8].
Furthermore, the failure of ManLAMs and AraLAM to
induce MKP-1 expression could be related to the inability of
these lipoglycans to be recognized by TLR2. Indeed, these
lipoglycans have been shown to preferentially recognize den-
dritic cell-speciﬁc ICAM-3 grabbing non-integrin (DC-SIGN)
and mannose receptors rather than TLRs [5].
The presented data suggest that mycobacteria may regulate
the immune response through the induction of MKP-1 by
LM. Previous reports have shown that infection with virulent
and non-pathogenic mycobacterial species diﬀerentially aﬀects
the level and duration of the MAPK phosphorylation
[11,28,29]. Indeed, murine macrophages infected with the viru-
lentM. avium 724 strain exhibit an early but short activation of
p38 and ERK1/2. In contrast, MAPK activation in macro-
phage infected with non-pathogenic strains remains elevated,
even 24 h after infection. Nevertheless, since LM from both
pathogenic and non-pathogenic was found to induce MKP-1
expression, the signiﬁcance of MKP-1 expression by LM, in
relation to pathogenesis is not clear. However, the LM/LAM
ratio was highly variable in diﬀerent mycobacteria, as example
from 9:1 (mol:mol) in M. chelonae and 3:1 in M. kansasii (6,
21, 22). One can speculate that the presence of large amounts
of LM in the cell walls of various pathogenic mycobacteria
may inﬂuence the host immune defenses through the up-regu-
lation of MKP-1. Furthermore, it would be interesting to
investigate whether LAM could down-regulate the eﬀect of
LM.
In conclusion, our study describes for the ﬁrst time that LM
regulates MKP-1 expression in macrophages. In further inves-
tigations, the ability of knockout mice defective in MKP-1 or
overexpressing MKP-1 in immortalized cells will help to deﬁne
the importance of MKP-1 in the host defence mechanisms
induced by LM during mycobacterial pathogenesis.
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